MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3 by Saeb-Parsy, K et al.
MT1-MMP regulates urothelial cell invasion via transcriptional
regulation of Dickkopf-3
K Saeb-Parsy*,1, A Veerakumarasivam
2, MJ Wallard
2, N Thorne
3, Y Kawano
4, G Murphy
5, DE Neal
1, IG Mills
1
and JD Kelly
2
1Department of Uro-Oncology, CRUK Cambridge Research Institute, Cambridge CB2 0RE, UK;
2Huchison/MRC Research Centre, Cambridge CB2 0XZ,
UK;
3Department of Bioinformatics, CRUK Cambridge Research Institute, Cambridge CB2 0RE, UK;
4Department of Oncology, Imperial College London,
London W12 0NN, UK;
5Department of Tumour Micro-Environment, CRUK Cambridge Research Institute, Cambridge CB2 0RE, UK
Membrane type-1 matrix metalloproteinase (MT1-MMP) is a zinc-binding endopeptidase, which plays a crucial role in tumour growth,
invasion and metastasis. We have shown previously that MT1-MMP has higher expression levels in the human urothelial cell
carcinoma (UCC) tissue. We show here that siRNA against MT1-MMP blocks invasion in UCC cell lines. Invasion is also blocked by
broad-spectrum protease and MMP inhibitors including tissue inhibitor of metalloproteinase-1 and -2. Membrane type-1-MMP can
also regulate transcription. We have used expression arrays to identify genes that are differentially transcribed when siRNA is used to
suppress MT1-MMP expression. Upon MT1-MMP knockdown, Dickkopf-3 (DKK3) expression was highly upregulated. The stability of
DKK3 mRNA was unaffected under these conditions, suggesting transcriptional regulation of DKK3 by MT1-MMP. Dickkopf-3 has
been previously shown to inhibit invasion. We confirm that the overexpression of DKK3 leads to decreased invasive potential as well
as delayed wound healing. We show for the first time that the effects of MT1-MMP on cell invasion are mediated in part through
changes in DKK3 gene transcription.
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Matrix metalloproteinases (MMPs) are a group of zinc-dependent
endopeptidases that regulate the pericellular microenvironment
and play an important role in development and physiological
regulation of the extracellular environment (Woessner, 1991;
Nagase et al, 2006). Membrane type-1 MMP (MT1-MMP) was
the first member of the membrane-bound MMPs to be identified,
and it plays a crucial role in tumour growth, angiogenesis, invasion
and, ultimately, development of metastasis (Sato et al, 1994; Zhou
et al, 2000; Sabeh et al, 2004; Itoh and Seiki, 2006).
Membrane type-1-MMP enhances degradation of collagen IV,
a major component of the basement membrane, by forming a
complex with tissue inhibitor of metalloproteinase-2 (TIMP-2) to
activate pro-MMP-2 (Seiki, 2003). The process of substrate activation
is a well-characterised function of MT1-MMP, and other substrates
requiring cleavage and shedding for activation, including MMP13,
CD44 and a-v-b-3, have been identified (Knauper et al, 1996; Kajita
et al, 2001; Beauvais and Rapraeger, 2003, 2004; Endo et al, 2003;
Nagano and Saya, 2004). Recently the functional role of MT1-MMP
has been extended beyond sheddase activity; MT1-MMP induces
VEGFA and Smad1 and the suggested mechanism is transcriptional
regulation (Sounni et al, 2004; Freudenberg and Chen, 2007).
Induction of VEGFA appears to be through the activation of src
kinase pathway, and the presence of catalytic and cytoplasmic
domains are crucial in this process, which suggests that MT1-MMP
is a transcriptional regulator of multiple targets (Sounni et al, 2004).
Bladder cancer or urothelial cell carcinoma (UCC) is the fifth
common malignancy in the United Kingdom (Cancer Research UK
(CRUK) cancer statistic 2003), and it is anticipated that in 2007
over 67160 new cases would be diagnosed in the United States of
America (Jemal et al, 2007). We have previously demonstrated that
of the MMPs, MT1-MMP is highly expressed in UCC, localising to
both the epithelial and stromal compartments and associated with
stage and grade progression (Wallard et al, 2006). Expression of
MT1-MMP is highest in tumours invading the lamina propria
(pT1) and detrusor muscle (4pT2). This expression is in keeping
with the propensity for up to 20% of pT1 tumours to progress to
muscle invasive disease, and for up to 50% of muscle invasive
tumours to metastasis, within 2 years (Torti and Lum, 1984).
In this study, we explored the potential downstream events
following targeted manipulation of MT1-MMP in UCC cell lines.
We employed expression microarray to highlight changes in the
expression of genes following suppression of MT1-MMP. Among
candidate genes, we identified Dickkopf-3 (DKK3) as a putative
target, which appears to be transcriptionally suppressed by
MT1-MMP and by itself is a potent regulator of cell invasion.
Dickkopf-3, also known as reduced expression in immortalised
cells (REIC), is a divergent member of a group of four secreted
proteins, and emerging evidence suggests that it functions as a
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2004; Kawano et al, 2006). Dickkopf-3 may interact to inhibit wnt-
signalling pathways (Hoang et al, 2004), and its loss in UCC and
other cancers corresponds to a tumour suppressor effect (Nozaki
et al, 2001; Kurose et al, 2004; Kawano et al, 2006; Urakami et al,
2006). In support of an extended role for MT1-MMP, the results of
this study offer further evidence of interaction with other targets,
specifically with negative regulation of the antimigratory tumour
suppressor gene DKK3 in UCC.
MATERIALS AND METHODS
Cell lines and culture
Urothelial cell carcinoma cell lines RT112, 253JBV and EJ28 were
sourced from CRUK. UMUC3 and HT137 were sourced from the
American Type Culture Collection. UMUC3, 253JBV and 253JBV
were grown in RPMI 1640 supplemented with 10% foetal bovine
serum. The remainder of the cell lines were grown in DMEM
supplemented with 10% foetal bovine serum. Cells were main-
tained at 371C in a humidified incubator containing 95% air and
5% CO2.
Constructs
pCS2-hDKK3 and pCDNA-T05 empty vectors were kind gifts
from Y Kawano (Imperial college, London, UK) and J Girling
(Cambridge Research Institute, Cambridge, UK), respectively.
FuGENE 6 (Roche, Welwyn Garden City, UK) was used for
transfection.
Cell culture treatments
Cells were treated for 24h with synthetic and physiological
protease inhibitors: aprotinin (10mgml
 1), BB94 (5mM), TIMP-1
(500nM) and TIMP-2 (500nM) in growth media. For functional
studies, cells were pretreated as above and maintained in media
with the inhibitor throughout the experiment. For invasion assays,
inhibitors at the above-mentioned concentrations were also added
to the Matrigelt mix. Aprotinin, BB94 and purified recombinant
TIMP-1 and TIMP-2 were kind gifts from Professor Murphy.
siRNA transfection
siGENOME Individual Duplex Human MT1-MMP siRNA
and siCONTROL non-targeting siRNA were purchased from
Dharmacon (Chicago, IL, USA) and used at 20mM. Opti-MEMt
transfection media and oligofectaminet (both from Invitrogen,
Paisley, UK) were used to transfect the cells once they reached 50%
confluency. Knockdown was assessed by both quantitative reverse-
transcriptase polymerase chain reaction (qRT-PCR) and western
blot analysis. To block transcription, 24h following the knock-
down of MT1-MMP, cells were incubated in serum-free media
for 12h and actinomycin D (10mgml
 1) was added. Cells were
harvested at time 0 as well as time points 1, 2, 4 and 8h following
the addition of actinomycin D, and qRT-PCR analysis was
performed for DKK3 and MT1-MMP mRNA expression.
Isolation of secreted DKK3 from media
Following knockdown of MT1-MMP, cells were grown in opti-
MEM (Invitrogen). Media were concentrated using Vivaspin
column (pore size 1 10
5; Vivascience, Munich, Germany).
Western blot analysis
Cell pellets were resuspended in modified RIPA buffer (50mM Tris
(pH 7.8), 150mM NaCl, 5mM EDTA, 15mM MgCl2, 1% NP-40, 0.5%
sodium deoxycholate, 1mM DTT, protease inhibitors 1:100, 20mM
N-ethylmaleimide) and further disrupted by mechanical shearing
through a 19-gauge needle. Soluble proteins were then separated
by centrifugation at 41C for 5min. Concentration of protein was
calculated using a Bio-Rad protein assay kit (Bio-Rad, Hemel
Hempstead, UK). Proteins were run on 10% SDS-PAGE and
blotted on nitrocellulose membrane and incubated with appro-
priate primary antibodies. The membranes were incubated with
horseradish-peroxidase-labelled secondary antibody. The mem-
branes were washed and developed with ECL Plus western blotting
detection system (Amersham, Little Chalfont, UK). The MT1-MMP
antibodies were kindly donated by Professor Murphy and used at a
concentration of 1.5mgml
 1; 350-amino-acid isoform of DKK3
antibody (Abcam, Cambridge, UK) was used at 1mgml
 1.
Reverse transcription and qRT-PCR
RNEasy (Qiagen, Crawley, UK) extraction and purification kits
were used to extract total RNA from cell pellets according to the
manufacturer’s recommendations. SuperScriptt III first-strand
synthesis system (Invitrogen) and random hexamer primers were
used to reverse transcribe 2mg of total RNA according to the
manufacturer’s recommendations. Amplification by PCR was
carried out in a final volume of 10ml containing 1.5mlo f
reverse-transcribed cDNA, 5ml of SYBER Green PCR master mix
(Applied Biosystems, Warrington, UK) and 2pmol of primers. ABI
PRISM 7900 HT sequence detection system (Applied Biosystems)
with the following PCR conditions was used: 501C for 2min, 951C
for 10min, 40 cycles of 951C for 15s and 601C for 1min. As
normalisation standards, GAPDH and SDH were used. Dickkopf-3
QuantiTech
s primer assay (Qiagen) was used. The MT1-MMP,
SDH and GAPDH primers were designed using the Primer Express
software (Applied Biosystems). Sequences of the primer pairs were
as follows: MT1-MMP, forward primer 50-TGCCATGCAGAAGTT
TTACGG-30 and reverse primer 50-TCCTTCGAACATTGGCCTTG-30;
GAPDH, forward primer 50-GCAAATTCCATGGCACCGT-30 and
reverse primer 50-TCGCCCCACTTGATTTTGG-30;S D H ,f o r w a r d
primer 50-TGGGAACAAGAGGGCATCTG-30 and reverse primer
50-CCACCACTGCATCAAATTCATG-30.
Expression array analysis
Amino Allyl Message Amp kit (Ambion, Warrington, UK) was
used according to the manufacturer’s recommendation for
amplification and labelling of RNA. In brief, 10mg of amplified
RNA was resuspended in 6.7ml of nuclease-free water, 4.5mlo f
DMSO, 3.3ml of NaHCO3 (pH 9) and 4.5ml of Cy3 or Cy5. Labelled
amplified RNA were hybridised to 22k CRUK human cDNA
expression array slides (ICR Array Facility, Surrey, UK).
Matrigel invasion assay
A modified Boyden dual chamber was used to assess directional
migration of the cells. In brief, 10mg of growth-factor-reduced
Matrigel (BD Biosciences, Oxford, UK) in a total of 40ml of serum-
free media was applied to the upper chamber of 8-micron-pore cell
culture insert (Becton Dickinson, Oxford, UK) and allowed to set
over 2h. A total of 5 10
4 cells were suspended in serum-free
media and added to the upper chamber. Serum-positive media
were used as chemoattractant in the lower chamber.
After a 24h incubation period at 371C, 5% CO2, the media
and cells remaining in the upper chamber were removed using a
cotton bud. The insert was fixed in methanol and stained using
haematoxylin. The membrane was removed from the insert and the
number of invading cells was quantified by counting the cells in four
random per high-power fields and calculating the mean number of
invading cells. All experiments were performed in triplicate.
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A total of 1 10
6 cells were seeded onto a six-well plate and allowed
to reach full confluence. The monolayer was wounded using a
cocktail stick. Cells were incubated with appropriate media, as
stated. Digital images were taken at times 0, 24 and 48h. The mean
area was calculated using Internet-based software Image J (http://
www.rsb.info.nih.gov/ij/download.html) and compared to time 0.
MTT cell proliferation assay
A total of 5000 cells were plated onto flat-bottomed 96-well plates
and maintained overnight. Cells were incubated with 20ml of MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
for 2h. A volume of 200ml of DMSO was added and the
absorbance measured at 492nm.
RESULTS
Reducing MT1-MMP through siRNA leads to a reduction
of invasive phenotype
We examined the expression of MT1-MMP mRNA in a bank
of UCC cell lines, and detected the highest levels in EJ28
cells (Figure 1A), which is the most invasive cell lines,
as demonstrated by Matrigel invasion assay (Figure 2A).
We confirmed that EJ28 cell invasion was dependent on MT1-
MMP by siRNA transfection. Effective reduction of endogenous
MT1-MMP was confirmed by western blot analysis and qRT-PCR
over 120h (Figure 1B and C) and a 70% reduction of cell invasion
(Po0.05) was detected, when compared with wild-type and
scrambled control (Figure 1D).
Protease and MMP inhibition reduces invasive potential
Urothelial cell carcinoma cell lines were cultured with
synthetic and physiological protease inhibitors, including BB94,
aprotinin, TIMP1 and TIMP2, and invasion was assessed by the
Matrigel assay. As shown in Figure 2A, treatment of EJ28 and
HT1376 with aprotinin lead to a 45% reduction in invasiveness;
treatment of EJ28 and HT1376 with BB94 to a 79% and a 55%
reduction in invasiveness, respectively. Protease inhibition
reduced the invasive capacity of the EJ28 cells, but had limited
effect on 253JBV and UMUC3, which expressed low and moderate
levels of MT1-MMP, respectively. Targeting the soluble MMPs,
such as MMP2 and 13, by TIMP1 lead to a 44% reduction
of invasion in EJ28 cells, whereas inhibition of all MMPs, including
MT1-MMP, by TIMP2 lead to a 74% reduction (Po0.0005)
(Figure 2B).
Expression array identifies potential targets of MT1-MMP
in EJ28 cells
To explore putative targets of MT1-MMP, we employed expression
microarray to highlight differential gene transcript expression
following knockdown of MT1-MMP.
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Figure 1 Relative expression of MT1-MMP in UCC cell lines and siRNA-mediated downregulation of MT1-MMP. (A) Quantitative RT-PCR of MT1-MMP
mRNA. Total RNA was extracted from cultured cell lines and qRT-PCR was performed. As housekeeping genes, SDH, UBC and GAPDH were used. EJ28
cells have the highest expression levels of MT1-MMP. (B) Western blot of nontransfected control (C), scrambled control transfected (SC) and MT1-MMP
siRNA transfected (MT1-MMP siRNA) EJ28 cells at 24 and 48h. (C) Quantitative RT-PCR of MT1-MMP mRNA. (D) Matrigel invasion assay of
nontransfected, scrambled control transfected and MT1-MMP siRNA transfected EJ28 cells. A total of 5 10
4 cells were seeded and the number of cells
invading through the Matrigel was counted at 24h; *Po0.05 between MT1-MMP siRNA and C or SC groups.
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expression ratio following downregulation of MT1-MMP in EJ28
cells compared with controls. Functional analysis of these genes
using gene ontology annotation through DAVID (data base for
annotation, visualization and integrated discovery) revealed
involvement in the regulation of cell growth and maintenance,
signal transduction as well as regulation of cell cycle. Of the targets
identified, our interest was drawn to DKK3, which was among the
top five upregulated genes. Dickkopf-3 has been shown to act as a
tumour suppressor and inhibit cell invasion (Niehrs, 2006) and is
potentially negatively regulated by MT1-MMP. We confirmed this
by transient knockdown of MT1-MMP at 48h. Dickkopf-3 mRNA
levels were increased 1.8-fold compared with scrambled control
(Figure 3A), and an increase in secreted protein was confirmed in
the culture media of MT1-MMP-suppressed EJ28 cells (Figure 3B).
Densitomeric analysis of the western blot revealed that a 1.8-fold
increase in mRNA levels corresponds to over 3-fold increase in
protein level, as compared to a nontransfected control (Figure 3C).
Increased levels of DKK3 following the knockdown of
MT1-MMP is not as a result of mRNA stability
To determine whether knockdown of MT1-MMP in EJ28 cells
affects DKK3 mRNA stability, we examined the effect of
actinomycin D, an inhibitor of RNA transcription, on DKK3
mRNA levels following knockdown of MT1-MMP. In the absence
of actinomycin D, the DKK3 mRNA expression was increased 2.5-
fold following knockdown of MT1-MMP compared with scrambled
control siRNA. In the presence of actinomycin D, DKK3 mRNA
levels decreased progressively over time with minimally detectable
levels of DKK3 mRNA after 8h. The DKK3 mRNA levels at 8h
showed no statistical difference with negative control condition
where no mRNA was added (P40.10). These data suggest that
upregulation of DKK3 is not because of enhancement of mRNA
stability but as a result of transcriptional activation (Figure 3D).
DKK3 reduces directional migration of EJ28 cells
To explore the effects of DKK3 on tumour cell migration,
conditioned medium was enriched for DKK3. Conditioned media
were derived from transient transfection of Cos-7 cells with pCS2-
hDKK3, a wild-type construct, or pCDNA-T05 empty vector, and
migration was assessed through Matrigel and by the scratch test
assay. Addition of DKK3 conditioned media lead to a 75%
reduction in the invasive capacity of wild-type EJ28 cells
(Po0.0005) (Figure 4A and B). In keeping with this finding,
DKK3-conditioned media lead to a 37 and 30% reduction in closure
of scratched monolayer at 24 and 48h, respectively, when compared
with controls (Po0.01) (Figure 4C and D). Interestingly, addition of
broad-spectrum MMP inhibitors aprotinin and BB 94 did not alter
the rate of closure of scratched monolayer. However, addition of
DKK3 to aprotinin and BB94 lead to a 40 and 37% reduction of the
scratched monolayer, respectively (Figure 4E). We have already
shown that inhibition of MMP reduces the invasive potential of UCC
cell lines, as demonstrated by Matrigel invasion assay. However,
these data suggest that in two-dimensional culture, MMPs may not
play a significant role in would healing (scratch test), but DKK3
plays a more central role in both invasion and migration.
DISCUSSION
We have previously shown that among MMPs, MT1-MMP is highly
expressed and associated with high grade and stage UCC (Wallard
et al, 2006). In keeping with our previous report we have now
demonstrated that MT1-MMP was expressed in all the UCC cell
lines tested and high levels were detected in the more invasive cell
lines. In addition, suppression of MT1-MMP using siRNA
technology effectively inhibited invasion in these lines. These
findings are in accordance with the accepted role in which MT1-
MMP modifies the pericellular microenvironment to promote
invasion and spreading of tumour cells (Itoh and Seiki, 2006).
There is emerging evidence that the cytoplasmic domain of
MT1-MMP and its Src-dependent phosphorylation play a role in
modulation of cell migration (Nyalendo et al, 2007). Sounni et al
and Freudenberg et al have recently suggested that MT1-MMP has
additional transcriptional activation properties, which may be
involved in angiogenesis as well as in cell invasion and motility.
Transcriptional activation of VEGF-A appears to be mediated via
Src tyrosine kinase (Sounni et al, 2004), whereas induction of
Smad1 is mediated via TGF-b signalling (Freudenberg and Chen,
2007). In invasive cell lines, we confirmed that broad-spectrum
protease (aprotinin) and MMP inhibitors (BB94, TIMP1 and
TIMP2), as well as direct targeting of MT1-MMP, inhibited
invasion. These data support our previous observations in clinical
samples and suggest that MT1-MMP is a critical MMP promoting
UCC cell invasion. The inhibition of invasion upon targeting MT1-
MMP by TIMP2 and the less striking effect of TIMP1 on EJ28 cells
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Figure 2 Effect of MMP and protease inhibitors on invasion of various cell lines. (A) A total of 5 10
4 cells incubated in control media or in the presence
of various inhibitors (aprotinin, BB94, TIMP1 or TIMP2) for 24h and the number of cells invading through the Matrigel counted. (B) Effects of TIMP1 and
TIMP2 on invasion of EJ28 cells; **Po0.0005 between TIMP2 and control group.
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contributing to EJ28 cell invasion. To further indirectly support
the notion that factors other than activation of MMP2 play a role in
invasion of EJ28 cells, profiling of UCC cell lines showed that EJ28
cells express one of the highest levels of MT1-MMP, whereas their
MMP2 expression levels are low compared with other cell lines
(Supplementary data).
Using a corneal myofibroblasts model, Ottino et al (2005) have
also shown that activation of MT1-MMP by inflammatory
mediator platelet activation factor does not result in increased
MMP2 activity, suggesting an alternative pathway for extracellular
matrix (ECM) remodelling in the cornea.
We explored potential MT1-MMP-related targets and used
expression array technology to identify gene alterations following
suppression of MT1-MMP in EJ28 cells. Of the targets identified,
our interest was drawn to DKK3, which is a tumour suppressor
and inhibits cell invasion (Niehrs, 2006).
In this study, expression of DKK3 was induced following
downregulation of MT1-MMP and elevated levels of the protein were
detected in the growth medium of MT1-MMP-repressed cells.
Overexpression of DKK3 in conditioned media lead to significant
reduction of invasion in UCC. Expression levels of DKK3 mRNA
decreased progressively over time following incubation with actino-
mycin D, suggesting transcriptional regulation of DKK3 by MT1-
MMP rather than mRNA stability. These results support studies that
point toward a role in which MT1-MMP controls the transcriptional
regulation of a number of genes important in the tumour progression
machinery. As far as we are aware, modulation of DKK3 by MT1-
MMP has not been reported previously. Whether this transcriptional
regulation is a direct or an indirect effect remains to be elucidated.
One possible explanation for this transcriptional effect observed
could be internalisation of MT1-MMP and, in particular, localisation
of the cytoplasmic domain in the nucleus and direct effect on
transcription (Ip et al, 2007). This mechanism has previously
been implicated in the regulation of transcription by the ErbB4 and
Notch receptors, which require proteolytic cleavage and nuclear
translocation of their cytoplasmic domains. However, this
may represent a rather unique case and it is more commonly
accepted that degradation of the ECM by MT1-MMP modulates
signals generated by integrin–ECM interactions, which consequently
affect gene transcription. A further consideration would be
transcriptional regulation as an indirect result of activation of
other pathways.
Future work
There remain many unanswered questions regarding the
exact mechanism of modulation of DKK3 by MT1-MMP. Indeed,
it would be very interesting to pose the question that in view
of the fact that DKK3 is considered to be a tumour suppressor
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Figure 3 Expression of DKK3 following targeted suppression of MT1-MMP and effects of actinomycin D on DKK3 mRNA. (A) Quantitative RT-PCR of
DKK3 mRNA following knockdown of MT1-MMP (Si) and scrambled control (SC) at 24 and 48h expressed as a ratio of untreated controls. (B) Western
blot analysis of DKK3 secreted in media following knockdown of MT1-MMP at 48h compared to scrambled control (SC) transfection and wild-type EJ28
cells (C48). Actin control was used against the cell lysate, whereas amphiregulin control was used against the media. (C) Densitometric analysis of the
western blot shown in (B). Image J software was used to calculate the integrated density of the inverted image and expressed as a ratio in comparison with wild-
type EJ28 cells (C48) (D) Following the MT1-MMP knockdown and scrambled control, transfection cells were incubated with actinomycin (10mgml
 1) for 0, 1,
2, 4 and 8h. The DKK3 mRNA levels were analysed by qRT-PCR and normalised against the housekeeping genes SDH and GAPDH. NTC, negative control.
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back loop. To establish the mechanism of the modulation of DKK3
by MT1-MMP, we plan to use various mutants of MT1-MMP in
our knockdown system to investigate the contribution made by
various elements of MT1-MMP protein.
In conclusion, we have shown that MT1-MMP is essential for
the invasion of UCC cell lines, and involves hitherto unreported
mechanisms. Membrane type-1-MMP appears to transcriptionally
modulate DKK3 levels, which is a potent inhibitor of invasion.
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